Position in CGC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,380
+$1,217 QoQ
Shares Held
10,938
+45.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Jun 30, 2025CallValue
$90,890
CallShares
74,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RAYMOND JAMES FINANCIAL INC holds $784,401,544 across 37 Drug Manufacturers - Specialty & Generic names. CGC ranks #37 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,166,615 | $374,325,557 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
601,487 | $79,239,894 | |
| 3 | HLN |
Haleon plc
|
6,264,041 | $62,703,048 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,816,715 | $54,719,453 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,898,337 | $45,427,201 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
556,460 | $32,981,383 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
47,576 | $28,211,615 | |
| 8 | VTRS |
Viatris Inc
|
1,855,553 | $25,068,518 |
All Filings in CGC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,380 | 10,938 | Shares | Defined | 2026-05-14 | |
| 2025-06-30 | $90,890 | 74,500 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $9,163 | 7,511 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||